Your Hospice PBM Was Acquired Last Year. The Changes Are Arriving Now.

The Short Version

The acquisition announcement promises continuity. The buyer's integration plan is the document that actually governs what happens next, and you will never see it.

An acquisition is a re-evaluation you did not schedule. The contract survived the closing; the company you evaluated did not.

Integrations run on 12-to-24-month schedules. If your vendor changed hands in 2025, the consequential changes are arriving in this window, not last year's.

Watch five things: your account team, formulary committee cadence, network composition, support routing, and invoice format. And snapshot your own metrics this week.

The email arrived sounding like good news. An exciting next chapter. Expanded resources. A shared commitment to the patients you serve. And, always, the same reassurance near the end: you should expect no changes to your service. A wave of hospice pharmacy vendors changed hands in 2025, so if yours was among them, that email is sitting in your inbox somewhere, most of a year old by now. The people who wrote it probably meant it. But acquisition integrations run on 12-to-24-month schedules, which means the period the email was reassuring you about is the one your hospice is in right now.

A renegotiation you did not schedule

The contract survives the closing. What does not survive is the company you evaluated when you signed it. The account team that knew your program, the executives whose priorities shaped your service, the economics that made your terms make sense: all of it now belongs to an owner who bought a book of contracts in order to optimize it. That is not sinister. It is what acquisitions are for. Buyers have integration targets, synergy commitments, and investors who expect the combined company to earn more from the same clients than two separate companies did.

Which raises the only question that matters for your hospice: earn more from whom?

You evaluated a company. You are now served by a different one. The rational response is to evaluate again, on your schedule rather than theirs.

What changes first

Watch for these as the integration reaches you

→Your account team. The person who knew your formulary history and your pet issues is the most likely position to be consolidated. When a regional manager covering seventy accounts replaces them, service has changed, whatever the email said.

→Formulary committee cadence. Meetings that slip from monthly to quarterly, or new faces who treat your formulary as their formulary, are early signals of whose list it is becoming.

→Network composition. Watch for pharmacies quietly added or dropped, and for fills drifting toward locations the new owner has a relationship with.

→Support routing. The direct line that reached someone who knew your program tends to become a queue. Time-to-resolution is the number to track.

→Invoice format. A new invoice layout that shows less detail than the old one is rarely an accident. Visibility removed during integration seldom comes back on its own.

The review to run now

Do these now. If the deal closed months ago, none of this is too late: integration timelines mean the consequential changes are likely still ahead of you, or just beginning.

→Read your change-of-control and assignment clauses. Some agreements give you rights when ownership changes, including the right to exit. Most hospices have never had a reason to look.

→Request the formulary change history. What was covered the day the deal closed is your baseline for what happens to the list afterward. A vendor that hesitates to produce it is answering a different question.

→Snapshot your own metrics today. Pharmacy cost per patient day, rejection rate, time-to-fill, prior authorization turnaround. The ideal baseline was the day the deal closed; the second-best baseline is this week.

→Ask the six questions again. The answers your vendor gave when you signed may have been honest then. They have new owners now. The six questions worth asking any pharmacy vendor.

→Put a service review on the calendar. Six months out, with the new account team, against the metrics you just recorded. Make continuity something you verify rather than something you were promised.

The announcement email is sincere. The integration plan is the real document.

The structural question

Some pharmacy models change character when ownership changes because the margin lives where you cannot see it: inside the claims, inside the spread, inside the per-diem list. A new owner can re-tune those quietly, and the first place you will notice is your invoice, months later.

A fee-based model has nothing to re-tune. When the vendor's revenue is a visible price per patient day and the claims pass through at contract rates, ownership can change without your economics changing, because there is no hidden lever for a new owner to pull. That is the standard we built MerlinRx to, along with the part that keeps everyone honest: no long-term lock-in, so the relationship gets re-earned whether or not anyone gets acquired.

If your vendor was acquired last year, you did not choose this moment. It is still a good one to look around.

Want to see a different approach?

Schedule a conversation and see how MerlinRx handles this differently.

Schedule a Conversation